Recent Finacing
Recent Raise
Synedgen uses a glycochemistry platform to develop therapeutics and FDA 510(k)-cleared wound products SynePure and Catasyn, plus lead candidate SYGN305 for gastrointestinal mucositis, with R&D and manufacturing in Claremont.
